Boston Scientific lands in Minneapolis after a flight from an upstate New York airstrip

Boston Scientific’s Bombardier Challenger 650, N650BS, flew from Dream Field (PN98) in upstate New York to Minneapolis–Saint Paul International Airport (KMSP) on June 8, covering 1 hour and 52 minutes at 40,000 feet.

The flight lands in Minneapolis the same week the company is likely still briefing analysts and investors on the HI-PEITHO trial results for the EKOS Endovascular System, presented at the American College of Cardiology’s annual meeting in late March and published in the New England Journal of Medicine on March 28. The trial showed the EKOS system plus anticoagulation was superior to anticoagulation alone for intermediate-risk pulmonary embolism, as covered by Boston Scientific’s own press release. The company’s cardiology division, led by executive vice president Lance Bates, is headquartered in Maple Grove, Minnesota, just northwest of KMSP.

The Minneapolis stop continues a busy period for N650BS, which over the past two weeks has shuttled between Boston-area Hanscom Field, the U.S. capital region, and a private airstrip near the company’s upstate New York supplier known as Kollar’s Shoreview Marine Seaplane Base. With the MiRus investment closed in May and first-quarter 2026 results showing $5.2 billion in sales, the pattern suggests routine executive travel from the Marlborough, Massachusetts, HQ to the division’s operational nerve center in the Twin Cities.